Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Galenika A.D. Beograd
Legal Form: Joint Stock Company
Operational Status: Operational
Incorporation Date: 30-Apr-91
Galenika, a state-controlled firm established in 1945, was the first company in former Yugoslavia to be acquired by a foreign partner.
ICN Pharmaceuticals, which acquired a 75% stake in the drug maker under a 1990 agreement, planned to use it as a platform for growth in eastern Europe.
Serbia's government took over the Belgrade plant of ICN Pharmaceuticals in February 1999, after the commercial court in Belgrade ruled that ICN held a 35% stake and not 75%. Galenika claimed a 25% share of the Serbian
EMIS Benchmark Score
|Net sales revenue|
|Total operating revenue|
|Operating profit (EBIT)|
|Net Profit (Loss) for the Period|
|Operating Profit (EBIT) Margin|
|Return on Sales (ROS)|
|Return on Equity (ROE)|
|Debt to Equity|
|Company Tear Sheet|
|NAICS Industry Classification||✓||✕|
|Share Price information||✓||✕|
|Subsidiaries and Affiliates||✓||✕|
|Key Financial Highlights||✓||✕|
|Financial Performance Charts||✓||✕|
|Latest M&A and ECM Deals||✓||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✓||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.